Evidence map›Paper›PMID 38893928›Full record

ArticleMaterials (Basel, Switzerland)2024

Antipathogenic Applications of Copper Nanoparticles in Air Filtration Systems.

Subbareddy Mekapothula, Elvina Chrysanthou, James Hall, Phani Durga Nekkalapudi, Samantha McLean, Gareth W V Cave

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Engineering copper and copper-based materials for a post-antibiotic era.Frontiers in bioengineering and biotechnology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Subbareddy MekapothulaSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.ORCID 0000-0003-0391-3721
Elvina ChrysanthouSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.ORCID 0009-0005-2855-7614
James HallSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Phani Durga NekkalapudiSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Samantha McLeanSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.ORCID 0000-0001-8551-4307
Gareth W V CaveSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.ORCID 0000-0002-4167-1332

Funding

Nottingham Trent Univerity Vice Chancellor PhD studentshipWellcome Trust 106563
6 · The paper itself

Abstract

The COVID-19 pandemic has underscored the critical need for effective air filtration systems in healthcare environments to mitigate the spread of viral and bacterial pathogens. This study explores the utilization of copper nanoparticle-coated materials for air filtration, offering both antiviral and antimicrobial properties. Highly uniform spherical copper oxide nanoparticles (~10 nm) were synthesized via a spinning disc reactor and subsequently functionalized with carboxylated ligands to ensure colloidal stability in aqueous solutions. The functionalized copper oxide nanoparticles were applied as antipathogenic coatings on extruded polyethylene and melt-blown polypropylene fibers to assess their efficacy in air filtration applications. Notably, Type IIR medical facemasks incorporating the copper nanoparticle-coated polyethylene fibers demonstrated a >90% reduction in influenza virus and SARS-CoV-2 within 2 h of exposure. Similarly, heating, ventilation, and air conditioning (HVAC) filtration pre- (polyester) and post (polypropylene)-filtration media were functionalised with the copper nanoparticles and exhibited a 99% reduction in various viral and bacterial strains, including SARS-CoV-2,

Indexed as

antibacterial activityantiviral activitycopper oxide nanoparticlesnanoparticle-coated polymeric fibersSARS-CoV-2

Identifiers

PMID38893928
PMCPMC11173455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.